Sushma Swaraj admitted to Delhi's AIIMS after chest pain

New Delhi, Jan 28: The Supreme Court of India today granted bail to 17 convicts sentenced to life imprisonment in 2002 Gujarat massacre case, pending their appeal before the Supreme Court.

The convicts also have to participate in social and spiritual services, said the court, announcing the riders for bail.

The Bench of Chief Justice of India SA Bobde and Justices BR Gavai and Surya Kant directed for the convicts to be segregated into two groups to be sent to Indore and Jabalpur.

District legal authorities in Indore and Jabalpur in Madhya Pradesh have been asked to ensure that the convicts do the spiritual and social work the court has asked for.

The Supreme Court has also asked the administration to find them work for livelihood. The state legal services authority has been asked to file a compliance report as also report on their conduct.

The case concerns the mass killing of 33 innocent Muslims - mostly women and children - who were burnt alive at Sardarpura village in March 2002.

This was part of the mass massacre that swept through Gujarat in the aftermath of the death of train passengers on Sabarmati Express in Godhra on Feb 27, 2002. Thousands of innocent Muslims were killed and raped in the three-day violence. The victims include hundreds of children including newborns.

In 2016, the Gujarat High Court had upheld the conviction of 17 accused in the Sardarpura massacre case.

Earlier, a Special SIT court had convicted a total of 31 persons in the case, after three years of trial against 73 persons from Sardarpura and nearby villages.

Bengaluru, Mar 6: At least 13 persons, including women and children, were killed and five critically wounded when an SUV collided with a car that had crashed against a road divider moments ago near Kunigal in Tumakuru district of Karnataka in the early hours of Friday, police said.

Of the victims, while 12 died on the spot, a child breathed his last in a hospital, they added.

The injured were admitted to the hospital, the police said.

Among the dead, 10 were from Tamil Nadu and three from Bengaluru. All of them were pilgrims who were on their way to Dharmasthala in Karnataka.

There were five women and two children among the dead, the police said.

"Thirteen persons have died. The incident occurred post midnight. A car crashed against the road divider and another car collided with it," Tumakuru Superintendent of Police (SP) K Vamsi Krishna said.

The police had to struggle to pull the bodies out from the mangled vehicles.

On learning about the incident, relatives of the victims rushed to the spot.

Bengaluru, Mar 28: Sun Tsu, in 'The Art of War' speaks of a skilful general who can subdue his enemy without any fighting. This constitutes the ultimate triumph which is referred to as stratagem. Today, we would need one such when we are faced with the '21-day corona challenge' for India.
Nearly four weeks back, Dr Jyothsna Rao, Dr Gururaj Rao and I sat across the OPD in the afternoon at HCG Bengaluru discussing our ongoing cancer immunology research. While on this topic, we drifted into the discussion on the coronavirus. During this engaging discussion, we wondered the similarity of the enigma between the virus and cancer. I paused to ask Dr Jyothsna and Dr Guru - how we wish we could do something against this virus.
Dr Jyothsna is a PhD from NCBS and had worked under Dr Ralph Steinman, physician and researcher from Rockefeller University, who won the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity in 2011. Dr Gururaj is a molecular and cell biologist who did his PhD at the Chapel Hill, University of North Carolina and is the Director of iCrest.
Jyothsna while hearing our perplexing conversation on the covid intervened, "Yes, surely. I think we should take a break from cancer and focus on the innate and adaptive immunity role in COVID-19."
Thus began this sincere attempt to relook the human immune system from the eyes of the COVID-19.
We have 10 types of immune cells at the least which are widely dispersed in millions across the body. When our body is invaded by a foreign organism (bacteria, fungi or virus), these cells work with each other to destroy the invader.
Now, the question is - how do the immune cells talk to each other? They use small-molecule substances called cytokines (cyto means cells; kine means movement). There are many cytokines that are involved in work on the immune system. The most relevant for viruses are interferons.
Interferons (IFN) as the name reflects have an ability to interfere with the viral activity and stop their multiplication. These specialised signal proteins are released by our cells in response to a viral attack to forewarn other cells. They help build the antiviral proteins within the cells to kill the virus as it tries to invade the new cells.
Historically, interferons are a group of cytokines known to be potent antiviral agents against viruses and a hallmark cytokine induced by the host upon viral infections. Interferons possess unique immunoregulatory activities and are signature cytokines released by (TH1) T immune cells, which are crucial in viral infections.
As the outbreak of COVID-19 grapples us, an urgent need for finding strategies to combat the virus is growing. Coronaviruses (CoVs) are a group of RNA viruses. In patients infected with coronavirus, it was indicated that the activation of the IFN does not occur until 48 hours post-infection. Thus the delayed IFN-related antiviral response by the healthy cells leads to coronavirus evade the immune response.
Numerous studies have presented the success in defeating CoVs by the direct administration of IFNs. In a combination as a concoction, it was shown to synergistically inhibit the virus replication in vitro.
Moreover, it is understood that the earlier induction of IFNs in children although they have a less developed immune system could be the reason behind the children being least affected.
The key to success in reducing the disease fatality might be the stimulation of the immune responses to trigger IFN production at the very early stages of the disease, which might be done through the administration of IFN. Despite the evidence for the efficacy of IFNs in treating CoV-induced infections, the proper dosing and ideal timing for such interventions needs to be verified in clinical trials.
For the later stages of the diseases in advance stages where patients are on ventilator and have developed respiratory distress, we propose to utilise the mesenchymal cells derived from donor bone marrow that have been known to treat acute respiratory syndrome. Mesenchymal cells are known to possess anti-inflammatory activity and thus used often in autoimmune diseases.
With this scientific background, we have activated T cells from healthy donors, in a cGMP facility at iCrest - HCG hospital with an enriched cocktail of cytokines rich in Interferons. Injections of this cocktail we believe will result in a surge of cytokines in the body of the infected person and will boost his ability to fight the virus in the early phases. We are in the initial phases of this study and hope to be ready in the coming weeks with meaningful data on its potential utility.
Currently, it awaits government approvals (Union and state) and we have applied to central drugs authority for their initial evaluation and further directions.
As my Guru often expounded the philosophy of 'Seva' - the goal of education is knowledge, the end goal of knowledge is service. In this attempt to serve our fellow humans at this brink of unprecedented crisis, medical fraternity stands with you and promises to do our best for your safety.
We assure to exhaust every bit of our spirit in this fight against coronavirus. We have lost the sight of shores and travelled thus far, but that is the mandatory first step to cross the ocean. Are we going to succeed in this battle, is something only time will answer.